Uric acid: A prognostic marker not only before but also after heart transplantation

European Journal of Cardio-thoracic Surgery

Volumn 38, Issue 2, 2010, Pages 187-191

  António, Natália ^a   Prieto, David ^a   Antunes, Manuel J ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Heart transplantation; Predictors; Rejection; Uric acid

Indexed keywords

TRIACYLGLYCEROL; URIC ACID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GROUP ABO SYSTEM; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; URIC ACID BLOOD LEVEL;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; EPIDEMIOLOGIC METHODS; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; PERIOPERATIVE CARE; PROGNOSIS; URIC ACID; YOUNG ADULT;

EID: 77954386435     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.01.018     Document Type: Article

References (26)

1. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Strömberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
2. Stewart S., Winters G.L., Fishbein M.C., Tazelaar H.D., Kobashigawa J., Abrams J., Andersen C.B., Angelini A., Berry G.J., Burke M.M., Demetris A.J., Hammond E., Itescu S., Marboe C.C., McManus B., Reed E.F., Reinsmoen N.L., Rodriguez E.R., Rose A.G., Rose M., Suciu-Focia N., Zeevi A., Billingham M.E. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005, 24:1710-1720.
3. Mehra M., Ventura H., Chambers R., Collins T., Ramee S., Kates M., Smart F., Stapleton D. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 1995, 26:1537-1544.
4. Raichlin E., Edwards B., Kremers W., Clavell A., Rodeheffer R., Frantz R., Pereira N., Daly R., McGregor C., Lerman A., Kushwaha S. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant 2009, 28:320-327.
5. Anker S.D., Doehner W., Rauchhaus M., Sharma R., Francis D., Knosalla C., Davos C.H., Cicoira M., Shamim W., Kemp M., Segal R., Osterziel K.J., Leyva F., Hetzer R., Ponikowski P., Coats A.J.S. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003, 107:1991-1997.
6. Hare J.M., Johnson R.J. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation 2003, 107:1951-1953.
7. Leyva F., Anker S.D., Godsland I.F., Teixeira M., Hellewell P.G., Kox W.J., Poole-Wilson P.A., Coats A.J.S. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 1998, 19:1814-1822.
8. Martínez-Dolz L., Almenar L., Reganon E., Vila V., Sánchez-Soriano R., Martínez-Sales V., Moro J., Agüero J., Sánchez-Lázaro I., Salvador A. What is the best biomarker for diagnosis of rejection in heart transplantation?. Clin Transplant 2009, 23:672-680.
9. Crescioli C., Buonamano A., Scolletta S., Sottili M., Francalanci M., Giomarelli P., Biagioli B., Lisi G., Pradella F., Serio M., Romagnani P., Maccherini M. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection. Transplantation 2009, 87:249-255.
10. Lindenfeld J., Miller G.G., Shakar S.F., Zolty R., Lowes B.D., Wolfel E.E., Mestroni L., Page R.L., Kobashigawa J. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation 2004, 110:3734-3740.
11. Hosenpud J., Bennett L., Keck B., Boucek M., Novick R. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J Heart Lung Transplant 2000, 19:909-931.
12. Eisen H., Hobbs R., Davis S., Laufer G., Mancini D., Renlund D., Valantine H., Ventura H., Vachiery J., Bourge R., Canver C., Carrier M., Costanzo M., Copeland J., Dureau G., Frazier O., Dorent R., Hauptman P., Kells C., Master R., Michaud J., Paradis I., Smith A., Vanhaecke J., Mueller E. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine-results at six months after transplantation. Transplantation 1999, 68:663-671.
13. Kobashigawa J., Miller L., Renlund D., Mentzer R., Alderman E., Bourge R., Costanzo M., Eisen H., Dureau G., Ratkovec R., Hummel M., Ipe D., Johnson J., Keogh A., Mamelok R., Mancini D., Smart F., Valantine H. The mycophenolate mofetil I. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients1. Transplantation 1998, 66:507-515.
14. Shuhaiber J.H., Goldsmith K., Large S.R., Tsui S. Does perioperative use of aprotinin reduce the rejection rate in heart transplant recipients?. Eur J Cardiothorac Surg 2008, 33:849-855.
15. Igor I., Kresh J.Y., Rohinton J.M., Susan C.B., Steven P.K., Andrew S.W. Early detection of acute allograft rejection by linear and nonlinear analysis of heart rate variability. J Thorac Cardiovasc Surg 2000, 120:737-745.
16. Sánchez-Soriano R.M., Almenar L., Martínez-Dolz L., Reganon E., Martínez-Sales V., Chamorro C.I., Vila V., Martín-Pastor J., Villa P., Salvador A. Diagnostic usefulness of inflammatory markers in acute cellular rejection after heart transplantation. Transplant Proc 2006, 38:2569-2571.
17. Billingham M., Cary N., Hammond M., Kemnitz J., Marboe C., McCallister H., Snovar D., Winters G., Zerbe A. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990, 9:587-593.
18. Karason K., Jernås M., Hägg D.A., Svensson P.A. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. BMC Cardiovasc Disord 2006, 6:29.
19. Perez-Villa F., Benito B., Llancaqueo M., Cuppoletti A., Roig E. Elevated levels of serum interleukin-6 are associated with low grade cellular rejection in patients with heart transplantation. Transplant Proc 2006, 38:3012-3015.
20. Athanassopoulos P., Vaessen L.M., Maat A.P., Balk A.H., Weimar W., Bogers A.J. Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responses. Eur J Cardiothorac Surg 2004, 25:619-626.
21. Bandukwala F., Huang M., Zaltzman J., Nash M., Prasad G. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Am J Cardiol 2009, 103:867-871.
22. Leyva F., Anker S., Swan J.W., Godsland I.F., Wingrove C.S., Chua T.P., Stevenson J.C., Coats A.J. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997, 18:858-865.
23. Brunner-La Rocca H.P., Sütsch G., Schneider J., Follath F., Kiowski W. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation 1996, 94:1334-1338.
24. Joshi A., Masek M., Brown B.J., Weiss L., Billingham M. " Quilty" revisited: a 10-year perspective. Hum Pathol 1995, 26:547-5557.
25. Fraund S., Pethig K., Franke U., Wahlers T., Harringer W., Cremer J., Fieguth H., Oppelt P., Haverich A. Ten year survival after heart transplantation: palliative procedure or successful long term treatment?. Heart 1999, 82:47-51.
26. Grimm M., Rinaldi M., Yonan N.A., Arpesella G., Arizón Del Prado J.M., Pulpón L.A., Villemot J.P., Frigerio M., Rodriguez Lambert J.L., Crespo-Leiro M.G., Almenar L., Duveau D., Ordonez-Fernandez A., Gandjbakhch J., Maccherini M., Laufer G. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients-a large European trial. Am J Transplant 2006, 6:1387-1397.